All Roads Lead to Change: Addressing Unmet Needs in the African American MS Community Web Activity


Annette Howard, MD
Medical Director
Multiple Sclerosis Institute of Texas
Click here for biography

Evelyn A. Hunter, PhD
Assistant Professor
Auburn University
Click here for biography

Gary A. Puckrein, PhD
President & CEO
National Minority Quality Forum
Click here for biography

Jacqueline Faulkner Rosenthal, MD
Clinical Neurologist
Andrew C. Carlos Multiple Sclerosis Institute Shepherd Center, Atlanta
Click here for biography

Richard L. Street, Jr., PhD
Texas A&M University
Click here for biography

Yolanda Wheeler, PhD, CRNP, CPNP-AC, MSCN
Assistant Professor, UAB School of Nursing
Pediatric Acute Care Nurse Practitioner, UAB Center of Pediatric Onset Demyelinating Disease
Click here for biography

Target Audience
This initiative is intended for neurologists, MS subspecialists, primary care clinicians, pharmacists, registered nurses, ER providers, social workers, case managers, and other health care professionals involved in the treatment and management of black patients with MS.

Statement of Need/Program Overview
Incidence rates of MS have been found to be higher in both black males and black females versus white males and white females. Disease progression is also significantly faster in black MS patients in both brain and retinal measures. Furthermore, African Americans are dying from MS at an earlier age, which suggests that MS burden weighs disproportionately across race demographics.

These observations suggest a need to identify and address barriers to appropriate MS care experienced by African American patients. Efforts to lower and overcome these and other barriers require recognition of the gaps in care as well as behavioral changes within the MS treater community to minimize initial treatment delays and attenuate disease progression.

Educational Objectives
At the conclusion of this activity, participants should be able to demonstrate improved ability to: 

Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Multiple Sclerosis Association of America, and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation:

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-21-2777-H04-P
Type of Activity: Knowledge

Continuing Social Work Education

As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.  Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 cultural competency continuing education credits.

Case Manager Continuing Education
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers.
The course is approved for 1 CE contact hour(s).
Activity code: I00046439
Approval Number: 210001807
To claim these CEs, log into your CCMC Dashboard at


Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Name of Faculty Reported Financial Relationship
Annette Howard, MD

Consulting fees (ex.advisory boards): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme
Fees for Non-CE Services Received Directly from an Ineligible Entity or their Agents (e.g., speakers’ bureaus): EMD Serono, Bristol Myers Squibb, Sanofi Genzyme

Evelyn A. Hunter, PhD Dr. Hunter has nothing to disclose
Gary A. Puckrein, PhD Dr. Puckrein has nothing to disclose
Jacqueline Faulkner Rosenthal, MD Consulting fees (ex. advisory boards): Genentech
Richard L. Street, Jr., PhD

Salary: Texas A&M University
Consulting fees (ex. Advisory boards): Associate Editor for Patient Education and Counseling, Rand Corporation

Yolanda Wheeler, PhD, RNP, CPNP-AC, MSCN

Salary: National MS Society
Consulting fees (ex.advisory boards): African American Advisory Board for the MSAA; Bafiertan Nurse Virtual Advisory Board for Banner Life Sciences

The PIM planners and others have nothing to disclose.
The MSAA planners and others have nothing to disclose.
The Impact Education, LLC® planners and others have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

  1. Successfully complete the post-test with a score of 75% or better
  2. Complete the evaluation form
  3. A CE certificate will be made available immediately to download and print.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account. Credit must be uploaded to CPE Monitor within 30 days.

There is no fee for this educational activity.